BPC-157 Studied IBS: Mechanism vs Clinical Application Comparison
Mucosal Healing Accelerated healing in rodent colitis models, 40–60% reduction in inflammation scores within 7–14 days No controlled trials in IBS populations; case reports suggest subjective improvement but lack validation Strong mechanistic plausibility, wea
This comparison does not assign a generated winner or score.
- Mucosal Healing
- Accelerated healing in rodent colitis models, 40–60% reduction in inflammation scores within 7–14 days
- No controlled trials in IBS populations; case reports suggest subjective improvement but lack validation
- Strong mechanistic plausibility, weak clinical confirmation
- Anti-Inflammatory Effect
- Reduced TNF-alpha, IL-6, and myeloperoxidase in induced gut injury models
- Not measured in IBS-specific trials; inflammatory markers not consistently elevated in all IBS subtypes
- Relevant for post-infectious or inflammatory IBS subtypes, less so for purely motility-driven IBS
- Visceral Pain Modulation
- Some evidence of reduced nociceptive signalling in rodent pain models
- No human data on visceral hypersensitivity or pain thresholds in IBS patients
- Theoretical benefit, no clinical validation
- Gut Barrier Function
- Improved tight junction integrity in Caco-2 cell monolayers and rodent permeability models
- Not assessed in human IBS trials; relevance depends on whether permeability is a primary driver in individual patients
- Potentially useful in leaky gut subtypes, not generalisable to all IBS
- Administration Route
- Effective via subcutaneous, oral, and intraperitoneal routes in animal studies
- Human case reports primarily use subcutaneous; oral bioavailability in humans not well-characterised
- Route selection remains empirical without pharmacokinetic data
- Safety Profile
- No significant adverse events in rodent toxicity studies up to 100x therapeutic dose
- Human safety data limited to small case series; no long-term follow-up or large cohort safety trials
- Appears well-tolerated short-term, but long-term safety unknown